http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2245166-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46f8cf263e27134018abc1983cfd08f6 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E50-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-649 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6432 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-64 |
filingDate | 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c77300c236e22d42c4e042fa5e46f00c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75d19a3e91ce97694cb7a7ddb5fec83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7caf74b202d65ba2172ae403b3a8a450 |
publicationDate | 2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2245166-A1 |
titleOfInvention | Very long chain polyunsaturated fatty acids, methods of production, and uses |
abstract | The present invention relates to processes for production of Very Long Chain Polyunstaturated Fatty Acids (VLC-PUFAs). The present invention also relates to compositions (e.g., nutritional supplements and food products) containing such VLC-PUFAs. In one embodiment, the present invention is directed to methods for biosynthesis and production of the VLC-PUFAs described herein (particularly C28-C38 PUFAs, also referred to herein as supraenes or supraenoics) by the expression, in a production host cell, of the full or partial sequence(s) of Elovl4 DNA/mRNA nucleic acids or ELOVL4 protein sequences encoded thereby, from any species (prokaryotic or eukaryotic) for use in the biosynthesis, production, purification and utilization of VLC-PUFAs in particular by the elongation of C18-C26 saturated fatty acids and PUFAs. The composition of the invention comprises, in various embodiments, a dietary supplement, a food product, a pharmaceutical formulation, a humanized animal milk, an infant formula, a cosmetic item and a biodiesel fuel for example. A pharmaceutical formulation can include, but is not limited to: a drug for treatment of neurodegenerative disease, a retinal disorder, age related maculopathy, a fertility disorder, particularly regarding sperm or testes, or a skin disorder. |
priorityDate | 2008-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.